The innovative drug concept rebounded. Harbin Pharmaceutical Co., Ltd. had 4 consecutive boards, Dizhe Pharmaceutical's 20cm2 continuous board, and Zhaoyan New Pharmaceutical hit a rise or fall, while Innox, Shiyao Innovation, Wisdom Pharmaceutical, and Borui Pharmaceutical followed suit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.